Relmada Therapeutics, Inc. (RLMD)

Last Closing Price: 3.11 (2026-11-19)

Normalized Pre-Tax Income (Quarterly)

Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.

Relmada Therapeutics, Inc. (RLMD) had Normalized Pre-Tax Income of $-10.82M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
--
$-13.86M
--
--
$13.10M
$-13.10M
$-0.77M
$-13.86M
Normalized Pre-Tax Income
$-10.82M
$-13.86M
$-13.86M
$-13.86M
$-10.82M
$-13.10M
$-13.10M
112.44M
112.44M
$-0.12
$-0.12
Balance Sheet Financials
$205.05M
--
$0.25M
$205.30M
$7.78M
--
$3.78M
$11.56M
$193.74M
$193.74M
$193.74M
106.69M
Cash Flow Statement Financials
$-37.26M
$-110.69M
$150.17M
$3.50M
$5.72M
$2.22M
$6.36M
--
--
Fundamental Metrics & Ratios
26.37
--
--
--
--
--
--
--
--
--
--
$-236.41M
--
--
--
--
--
--
--
-7.16%
-7.16%
-6.75%
-7.16%
$1.82
$-2.10
$-0.33